Prime Medicine, Inc. (PRME) Tops Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts PRME Hot Sheet
Join SI Premium – FREE
Prime Medicine, Inc. (NASDAQ: PRME) reported Q1 EPS of ($0.40), $0.04 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $1.45 million.
For earnings history and earnings-related data on Prime Medicine, Inc. (PRME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nayax Ltd. (NYAX) Misses Q2 EPS by 39c; reaffirms guidance
- Aspire Biopharma acquires automotive supplier DCS for $30M
- AMMO Inc. (POWW) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
